FI65370B - Foerfarande foer framstaellning av ett fast farmaceutiskt preparat - Google Patents

Foerfarande foer framstaellning av ett fast farmaceutiskt preparat

Info

Publication number
FI65370B
FI65370B FI782442A FI782442A FI65370B FI 65370 B FI65370 B FI 65370B FI 782442 A FI782442 A FI 782442A FI 782442 A FI782442 A FI 782442A FI 65370 B FI65370 B FI 65370B
Authority
FI
Finland
Prior art keywords
procedure
preparation
medicinal products
medicinal
products
Prior art date
Application number
FI782442A
Other languages
English (en)
Other versions
FI65370C (fi
FI782442A (fi
Inventor
Yuichi Yamamura
Ichiro Azuma
Katsusuke Ennyu
Osamu Aoki
Original Assignee
Yuichi Yamamura
Ichiro Azuma
Katsusuke Ennyu
Osamu Aoki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuichi Yamamura, Ichiro Azuma, Katsusuke Ennyu, Osamu Aoki filed Critical Yuichi Yamamura
Publication of FI782442A publication Critical patent/FI782442A/fi
Application granted granted Critical
Publication of FI65370B publication Critical patent/FI65370B/fi
Publication of FI65370C publication Critical patent/FI65370C/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55583Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588Adjuvants of undefined constitution
    • A61K2039/55594Adjuvants of undefined constitution from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI782442A 1977-08-09 1978-08-09 Foerfarande foer framstaellning av ett fast farmaceutiskt preparat FI65370C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9587177 1977-08-09
JP9587177A JPS5428813A (en) 1977-08-09 1977-08-09 Solid preparation containing cell membrane extract substance used as suspension when using same

Publications (3)

Publication Number Publication Date
FI782442A FI782442A (fi) 1979-02-10
FI65370B true FI65370B (fi) 1984-01-31
FI65370C FI65370C (fi) 1984-05-10

Family

ID=14149407

Family Applications (1)

Application Number Title Priority Date Filing Date
FI782442A FI65370C (fi) 1977-08-09 1978-08-09 Foerfarande foer framstaellning av ett fast farmaceutiskt preparat

Country Status (15)

Country Link
US (1) US4543253A (fi)
JP (1) JPS5428813A (fi)
AU (1) AU526788B2 (fi)
BE (1) BE869610A (fi)
CA (1) CA1118348A (fi)
CH (1) CH643459A5 (fi)
DE (1) DE2834893A1 (fi)
DK (1) DK153443C (fi)
FI (1) FI65370C (fi)
FR (1) FR2399844A1 (fi)
GB (1) GB2002229B (fi)
HU (1) HU179726B (fi)
IT (1) IT1098381B (fi)
NL (1) NL7808337A (fi)
SE (1) SE447629B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1206416A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
CA1206415A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
US4806350A (en) * 1986-04-18 1989-02-21 Norden Laboratories, Inc. Vaccine formulation
DD273198A5 (de) * 1986-06-09 1989-11-08 �������@�������k���Kk�� Verfahren zur herstellung eines modifikationsmittels
DE3727987A1 (de) * 1987-08-21 1989-03-02 Sleytr Uwe B Pharmazeutische struktur
US6090385A (en) * 1993-12-10 2000-07-18 Maes; Hubert Method of treating cancer
KR100628007B1 (ko) * 1998-07-16 2006-09-26 이치로 아즈마 세균의 균체성분을 유효성분으로 하는 암면역요법용 제제
AU2003254792A1 (en) * 2002-08-02 2004-02-23 Sumitomo Pharmaceuticals Company, Limited Bacterial cell wall skeleton component preparaion
CA2564180A1 (en) * 2004-04-22 2005-11-03 Dainippon Sumitomo Pharma Co., Ltd. Pharmaceutical preparation containing bacterial cell wall skeleton component
CN115300490B (zh) * 2021-05-07 2024-04-16 安徽远望乐桓药业有限公司 包含角鲨烯和甘露醇的药物组合物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3185623A (en) * 1960-05-31 1965-05-25 Smith Fred Preservation of animal semen
US3177117A (en) * 1961-12-26 1965-04-06 Joseph F Saunders Process for freezing blood
FR2268531B1 (fi) * 1974-04-25 1978-07-21 Anvar
DE2527636A1 (de) * 1974-06-20 1976-01-08 Anvar Verfahren zur herstellung von mycobakteriellen fraktionen
FR2345159A2 (fr) * 1976-03-26 1977-10-21 Anvar Agents solubles dans l'eau ayant des proprietes mitogenes et/ou immuno-stimulantes, obtenus a partir de cellules de nocardia, et leurs procedes de preparation
FR2345158A1 (fr) * 1976-03-26 1977-10-21 Anvar Agents mitogenes, provenant notamment de peptidoglycanes bacteriens

Also Published As

Publication number Publication date
DK352578A (da) 1979-02-10
HU179726B (en) 1982-11-29
CA1118348A (en) 1982-02-16
SE447629B (sv) 1986-12-01
JPS5428813A (en) 1979-03-03
FI65370C (fi) 1984-05-10
GB2002229A (en) 1979-02-21
IT1098381B (it) 1985-09-07
FI782442A (fi) 1979-02-10
DK153443C (da) 1988-12-05
IT7826609A0 (it) 1978-08-08
DK153443B (da) 1988-07-18
US4543253A (en) 1985-09-24
AU3879178A (en) 1980-02-14
NL7808337A (nl) 1979-02-13
BE869610A (fr) 1979-02-08
DE2834893A1 (de) 1979-02-22
AU526788B2 (en) 1983-02-03
CH643459A5 (de) 1984-06-15
FR2399844A1 (fr) 1979-03-09
FR2399844B1 (fi) 1982-08-20
GB2002229B (en) 1982-05-26
JPS631291B2 (fi) 1988-01-12
SE7808414L (sv) 1979-02-10
DE2834893C2 (fi) 1987-08-27

Similar Documents

Publication Publication Date Title
SE437767B (sv) Forfarande for framstellning av ett antitumorlekemedel
NO790358L (no) Fremgangsmaate for fremstilling av alkylendiaminderivater
FI792863A (fi) Foerfarande foer igaongsaettning av aongpanna med tvaongscirkulation
FI803935L (fi) Cyklo-oktapeptider och farmaceutiska preparat daerav foerfarande foer deras framstaellning och deras anvaendning
SE7801428L (sv) Forfarande for framstellning av cefemkarbonsyror
NO782484L (no) Fremgangsmaate for fremstilling av sulfobetainer
NO792404L (no) Fremgangsmaate for fremstilling av imidazolderivater
NO771578L (no) Fremgangsmaate for fremstilling av di-n-propyleddiksyre
NO794317L (no) Fremgangsmaate for fremstilling av pyrido-indolderivater
SE7804946L (sv) Forfarande for framstellning av gipsprodukter
NO150799C (no) Fremgangsmaate for fremstilling av lysergol-derivater
FI65370B (fi) Foerfarande foer framstaellning av ett fast farmaceutiskt preparat
FI781330A (fi) Foerbaettrad begraensare foer medelstroemmaengden av en straole
FI772319A (fi) Anordning foer orientering av med bindemedel foersedda lignocellulosahaltiga delar
FI65910B (fi) Foerfarande foer framstaellning av farmaceutiska preparat med laongtidsverkan
SE7803035L (sv) Forfarande for framstellning av tienopyridinderivat
NO784382L (no) Fremgangsmaate for fremstilling av tiazoldin-derivater
SE7800933L (sv) Forfarande for framstellning av 3-metylpyridin
NO802435L (no) Fremgangsmaate til fremstilling av tetrahydrokinolinderivater
NO780390L (no) Fremgangsmaate for fremstilling av oleandomycin-derivater
SE7800048L (sv) Forfarande for framstellning av farmaceutiska preparat
NO780389L (no) Fremgangsmaate for fremstilling av erytromycin-derivater
NO152254C (no) Fremgangsmaate til fremstilling av karbazolderivater
SE7809202L (sv) Forfarande for framstellning av 2-klorsulfinylazetidin-4-oner
NO792659L (no) Fremgangsmaate for fremstilling av karbostyrilderivater

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: ENNYU, KATSUSUKE

Owner name: AZUMA, ICHIRO

Owner name: AOKI, OSAMU

Owner name: YAMAMURA, YUICHI